DNA Link Inc (127120) — Capital Reinvestment Ratio
DNA Link Inc (127120) has a Capital Reinvestment Ratio of 0.52x as of December 2023, meaning it reinvests 1% of its operating cash flow (₩1.51 Billion) in capital expenditures (₩786.91 Million). See net asset quality index of DNA Link Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DNA Link Inc Capital Reinvestment Ratio (2020–2022)
This chart tracks DNA Link Inc's Capital Reinvestment Ratio across 2 annual periods. Check DNA Link Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for DNA Link Inc (2020–2022)
Year-by-year Capital Reinvestment Ratio for DNA Link Inc from 2020 to 2022. For live market cap and broader valuation context, see 127120 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 5.42x | ₩910.27 Million | ₩4.93 Billion | ▲ +319.1% |
| 2020 | 1.29x | ₩849.38 Million | ₩1.10 Billion | — |